This inventor holds 1 USPTO granted patent. Top assignee: Fujirebio Inc. (Fujirebio Kabushiki Kaisha). Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Noboyuki Fujii: Innovator in Fused DNA Technology
Introduction
Noboyuki Fujii is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of biotechnology, particularly in the area of fused DNA sequences. His innovative work has led to advancements that could have a profound impact on various applications in medicine and research.
Latest Patents
Noboyuki Fujii holds a patent for a "Fused DNA sequence, fused protein expressed from said fused DNA sequence and method for expressing said fused protein." This patent discloses a fused DNA sequence that comprises a DNA sequence of a heat-resistant protein, which is fused directly or indirectly to a DNA sequence coding a selected protein or peptide. The patent also details a method for expressing the fused protein, showcasing the potential for new biotechnological applications.
Career Highlights
Fujii is associated with Fujirebio Inc., a company that specializes in developing innovative diagnostic solutions. His work at Fujirebio has allowed him to explore the practical applications of his inventions in the biotechnology sector. With a focus on enhancing the understanding of protein interactions, his research contributes to the advancement of medical diagnostics.
Collaborations
Noboyuki Fujii has collaborated with notable colleagues such as Eiichi Ueno and Masahisa Okada. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the field of biotechnology.
Conclusion
Noboyuki Fujii's contributions to the field of fused DNA technology exemplify the importance of innovation in biotechnology. His patent and work at Fujirebio Inc. highlight the potential for advancements that can lead to significant improvements in medical diagnostics and research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile